Innovative Medicines Initiative-2 officially launches its 9th call on I&DT
Antimicrobial resistance, influenza, liver diseases, rheumatic diseases, drug safety and data quality are the areas chosen for funding six research projects under the 9th call of the Innovative Medicines Initiative 2 (IMI-2).
The IMI-2 has just released his 9th call – H2020-JTI-IMI2-2016-09-two-stage – with 6 research topics and submission deadline of short Proposals until the 26th of July 2016:
- Addressing the clinical burden of Clostridium difficile infection (CDI): evaluation of the burden, current practices and set up of a European research platform (part of the IMI New Drugs for Bad Bugs (ND4BB) programme)
– Development of immune tolerance therapies for the treatment of rheumatic diseases
– Data quality in preclinical research and development
– Next generation of electronic translational safety – NEXGETS
– Identification and validation of non-invasive markers across the spectrum of nonalcoholic fatty liver disease (NAFLD)
– Joint influenza vaccine effectiveness surveillance studies
All information, including the text of the competition, guidelines for the preparation of relevant applications and rules can be found here.
IMI promoted several webinars between the 11th and 29th of April, to disseminate information about the topics in this call, as well as the rules and procedures of applications. See the presentations and videos of the webinars here.
IMI-2 invites SMEs, patient organizations, regulatory authorities, universities, hospitals, health sector entities, etc. to form consortia and to apply to this call.
In the event of having the expertise sought but not yet possess the most appropriate partnership for new topics in this call, IMI offers a partner search tool (available here). In addition to this tool, there are other mechanisms to identify potential partners, so do not hesitate to contact us!
More information about the IMI-2
Contribute in an active way in this call and rely on CREATING HEALTH for the support that is needed, particularly in terms of potential partners and preparing applications!
Published on 05/05/2016
